cbp/ep300 bromodomain inhibitors gne-781 (Genentech inc)
90
Structured Review
Genentech inc
cbp/ep300 bromodomain inhibitors gne-781
Cbp/Ep300 Bromodomain Inhibitors Gne 781, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gne-781/gne+781/pm40156557-67-10-25
Average 90 stars, based on 1 article reviews
Cbp/Ep300 Bromodomain Inhibitors Gne 781, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gne-781/gne+781/pm40156557-67-10-25
Average 90 stars, based on 1 article reviews
cbp/ep300 bromodomain inhibitors gne-781 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Activation Assay:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Luciferase:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Quantitative RT-PCR:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Expressing:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Inhibition:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Histopathology:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Immunohistochemistry:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Western Blot:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Recombinant:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Chromatin Immunoprecipitation:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a RNA Sequencing Assay:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Multiple Displacement Amplification:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a Software:Article Title: Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 Article Snippet: The authors thankKarenGascoigne ( Article Title: Complexities in the role of acetylation dynamics in modifying inducible gene activation parameters Article Snippet: Where required, cells were treated with 1.2 nM 4SC202 (Selleckchem), 100 nM A485 (Selleckchem), 100 nM Article Title: Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Article Snippet: BioXcell Cat# BP0090 Biological Samples Human healthy PBMCs (under protocols reviewed and approved by the Western Institutional Review Board) Article Title: Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734 Article Snippet: The authors thank Article Title: Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Article Snippet: GNE-781, the molecule used in the current study, is a |
